Yabao Pharmaceutical Group Co., Ltd (SHA:600351)
6.92
+0.01 (0.14%)
Apr 29, 2026, 3:00 PM CST
15.33% (1Y)
| Market Cap | 4.79B +12.0% |
| Revenue (ttm) | 2.20B -13.1% |
| Net Income | 319.41M +34.4% |
| EPS | 0.46 +38.1% |
| Shares Out | 692.00M |
| PE Ratio | 15.08 |
| Forward PE | n/a |
| Dividend | 0.40 (5.79%) |
| Ex-Dividend Date | Feb 6, 2026 |
| Volume | 27,198,870 |
| Average Volume | 26,861,476 |
| Open | 6.87 |
| Previous Close | 6.91 |
| Day's Range | 6.81 - 6.93 |
| 52-Week Range | 5.86 - 8.68 |
| Beta | 0.11 |
| RSI | 59.46 |
| Earnings Date | Apr 25, 2026 |